The role of nuclear protooncogenes during erythroid cell differentiation was examined by transfecting exogenous c-fos and c-myb genes into mouse erythroleukemia cells, which can be induced to differentiate either with eryth-
tiation. Cells expressing exogenous c-fos gene, however, maintained high levels of c-myb mRNA after Epo treatment. This high level of c-myb transcripts was found to be due to block of transcription shutoff (or transcriptional activation) rather than to mRNA stabilization. It is concluded that the down-regulation of endogenous c-myb gene expression is a prerequisite for commitment of Epo-induced erythroid differentiation and that expression of c-myb gene may be indirectly regulated by c-fos gene product. We also concluded that early down-regulation of c-myc gene expression is not essential for erythroid differentiation and that gene regulation of chemically induced erythroid differentiation may differ from that of Epo-induced differentiation.
Hemopoiesis is regulated by a set of specific glycoprotein factors that affect the program for proliferation and differentiation of progenitor cells (1) . The interaction of a polypeptide hormone with specific cell-surface receptors on progenitor cells may induce a signal (a cascade of biochemical events) that is transmitted from the cell membrane to the nucleus. This signal may involve activation of a set of specific regulatory genes that determine ordered expression of specific genes during the transition of cells to a proliferating or differentiating state (2) . The protooncogenes c-myb, c-fos, c-myc, c-jun, and c-ski and the p53 gene, which encode nuclear proteins, have been suggested to play regulatory roles in specific gene expression related to DNA replication and cell differentiation (3) (4) (5) (6) (7) . Thus, these nuclear protooncogenes are specifically modulated in their expression during cell growth and differentiation. For instance, the expression of c-myc, c-fos, and c-jun genes is rapidly and transiently induced in response to mitogens and growth factors in various cell types (5, (8) (9) (10) . In contrast, expression of c-myc and c-myb genes decreases during differentiation of myeloid precursors to macrophages concurrent with an increase in c-fos gene expression (11) (12) (13) . Furthermore, erythroid differentiation induced by chemicals causes rapid and transient c-fos gene expression, followed by a biphasic decline of c-myb and c-myc transcripts (14) (15) (16) . It has not yet been fully established whether modulated expressions of nuclear protooncogenes represent obligate events in regulation of hemopoietic cell differentiation. This possibility has been investigated by using established hematopoietic cell lines capable of undergoing differentiation when exposed to various inducers as models. For example, it has been reported that maintenance of high levels of c-myc expression inhibits chemically induced differentiation of erythroleukemia cells (16) (17) (18) (19) . We have described the characterization of mouse erythroleukemia SKT6 cells (20) , which can be induced to differentiate with either natural inducer erythropoietin (Epo) (1, 21) or the chemical inducer dimethyl sulfoxide (DMSO).
To investigate the molecular mechanism of Epo-induced erythroid differentiation and to gain insight into the possible roles of nuclear protooncogenes during Epo-induced differentiation, we have investigated the regulation of their expression in SKT6 cells in response to this hormone. Moreover, by transfecting exogenous nuclear oncogenes c-fos and c-myb into SKT6 cells, we have studied the implications of dysregulation of the normal controls of their gene expression on erythroid differentiation.
MATERIALS AND METHODS
Cell Culture and DNA Transfection. Mouse erythroleukemia SKT6 cells have been described (20) . Where appropriate, recombinant human Epo (>70,000 units/mg; Kirin Brewery, Tokyo) and DMSO with or without CdC12 (5 ,uM) were added to cell culture at final concentrations of 0.5 unit/ml and 1.5%, respectively, and hemoglobin-positive cells were stained by 0.2% benzidine (20) after 4 days of induction. Transfections into SKT6 cells were performed by electroporation (22) in 0.8 ml of Dulbecco's phosphate-buffered saline containing 1-2 X i07 cells per ml, 11 mM glucose, and 20 ug of DNA. Cells were pulsed at 500 V and 25 ,uF twice on ice (Bio-Rad Gene Pulser). Stable transformants resistant to antibiotic G418 (1 mg/ml) were cloned by limiting dilution.
DNA Construction and Probe DNAs. To construct pMTfosSVneo, the BamHI site of pSV2neo (23) was filled in by the Klenow fragment, and the DNA was digested with EcoRI. Similarly, the HindIII-BamHI DNA fragment containing human metallothionein 11A promoter region (24) , of which the HindIII site was blunt-ended, was prepared. The Nae I site at position +41 in pc-fos(mouse)3 DNA (25) , which contains whole mouse c-fos genomic DNA, was replaced by a BamHI site, and an EcoRI site was added at the BamHI site at the 3' end of the c-fos gene. This BamHI-EcoRI fragment was ligated with the above two DNA fragments to generate pMTfosSVneo. To construct pMTmybSVneo, the plasmid pQ24/10.4, which contains the entire mouse c-myb cDNA Abbreviations: DMSO, dimethyl sulfoxide; CAT, chloramphenicol acetyltransferase; Epo, erythropoietin. tTo whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 85 (1988) 8901 coding sequence within a BamHI linker-adapted Sma I site at position 1 to the Sac I site at position 2449 (26) , was digested with Bgl II, filled in by the Klenow fragment, and digested with BamHI. The Sal I site of pMTfosSVneo, which is located between the stop codon and poly(A) signal, was filled in and partially digested with BamHI. The resulting BamHISal I and BamHI-Bgl II fragments were ligated to generate pMTmybSVneo. Probe DNAs used for hybridization were fos, 4.8 kilobases (kb) of the HindIII-BamHI fragment of pc-fos(mouse)3 (25) ; myb, 2.1 kb of the BamHI-Bgl II fragment of pQ24/10.4 (26) ; myc, 4.8 kb of the Xba I-BamHI fragment of pSVc-myc-1 (27) ; jun, pJUN plasmid DNA, which contains 0.95 kb of the BamHI-EcoRI fragment of v-jun DNA (28); ski, pCCLskiS plasmid DNA (29) ; and p53, pLTRp53cG plasmid DNA (30) .
RNA Analysis. Total cellular RNA was isolated as described (31) . Ten micrograms of poly(A) RNA was fractionated on 1% agarose gels containing 2.2 M formaldehyde (32) . Hybridizations with nick-translated probes were carried out for 36 hr at 40'C, and the filters were washed as described (14) . When the half-life of c-myb mRNA was measured, actinomycin D was added to the cell culture medium to a final concentration of S ,ug/ml and RNA was extracted at the specified time.
Nuclear Run-On Transcription Assay. Preinitiated transcripts in 2 x 107 nuclei were elongated, labeled with [32P]UTP in vitro, and extracted as described (33) . The labeled run-on transcripts (107 cpm/ml) were hybridized to 5 ,ug of oncogene DNA fragments cloned in mpl8 and mpl9 M13 vectors, to 5 Ag of mpl8 vector DNA, and to 2 ,ug of ,3-actin DNA on a slot blot. Hybridizations and washing were carried out as described (33) . Autoradiographs were exposed for 3 days with intensifying screens.
RESULTS
Relative mRNA Levels of Nuclear Protooncogene During Epo-or DMSO-Induced Erythroid Differentiation. The relative transcriptional levels of nuclear protooncogene following Epo-or DMSO-induced SKT6 cell differentiation were analyzed by RNA blot hybridization. Fig. LA shows the changes in relative mRNA levels of c-myb, c-fos, c-myc, c-jun, and c-ski protooncogenes and the p53 gene following Epo induction. c-myb mRNA levels rapidly decreased: by 80o in 1 hr, and declining further to much lower levels by 24 hr. In contrast, the levels of c-myc mRNA increased about 3-fold in 30 min and remained high during the initial 24 hr. No c-fos, c-jun, or c-ski mRNA was detected in this RNA blot analysis. High levels of p53 transcripts were observed, but there was no detectable change in concentration.
A 0051 2111244877 Hr DMSO-induced SKT6 cells, on the contrary, showed a rapid and transient increase in c-fos gene expression, associated with a biphasic deline of c-myb and c-myc mRNA levels (Fig. 1B) . These profiles of mRNA levels are similar to those of other chemically induced mouse erythroleukemia cells as reported previously (14, 15) . No c-jun or c-ski mRNA was detected, and high and constant levels of p53 mRNA were observed. These data suggest that the molecular mechanism and/or pathway of chemically induced erythroid differentiation in the nucleus may differ from those of Epo-induced differentiation. In particular, an increase in c-myc expression in Epo-induced SKT6 cells indicates that early reduction in c-myc levels is not an obligate event in erythroid differentiation.
Effects of Transfected Oncogenes on Erythroid Differentiation. To study the potential relationship between c-myb and c-fos expression and Epo (or DMSO)-induced erythroid differentiation, plasmids (pMTfosSVneo and pMTmybSVneo) that contain pSV2neo and human metallothionein promoter-regulated mouse c-fos (or c-myb) gene were constructed ( Fig. 2E ) and transfected into SKT6 cells by electroporation. More than 20 independent stable transformants were cloned from each transfection. Of these, two clones, each of which expressed the highest level of exogenous oncogene mRNA in the presence of CdC12 among the cloned transformants, were selected for further studies. All clones examined, however, expressed exogenous oncogene constitutively without heavy metals, and they showed only 2-to 3-fold induced expression with CdCl2 (data not shown). No changes in cell growth rate or in morphology were observed in these oncogene transfected cells.
To determine the differentiation potential of these transformants, the selected transformants (c-fos transformants clones 1 and 7 and c-myb transformants clones 3 and 8) were induced with Epo or DMSO, and hemoglobin-positive cells were stained by bendizine. Strikingly, all of these transformants failed completely to differentiate above background levels with Epo (Table 1) . Control SKT6 cells to which pSV2-neo was transfected showed >70% bendizine positivity with Epo (Table 1) , which was about the same as the level shown by untransfected SKT6 cells. Thus, the observed inhibition of differentiation by exogenous c-fos and c-myb expression was not due to a transfection artifact. Furthermore, the mixture of c-fos (or c-myb) stable transformants (>100 clones) similarly exhibited a differentiation block ( Table 1 ), indicating that these effects are not a specific character of the particularly cloned transformants. DMSOinduced differentiation of c-fos-or c-myb-transfected cells was inhibited >50% (Table 1) but not completely to the basal level as observed in Epo-induced differentiation. Fig. 2A) in the presence of CdCl2. Since no endogenous c-fos mRNA was detected in Epo-induced SKT6 cells (Fig. lA) , all c-fos transcripts observed here are likely to be exogenous mRNA. Interest- ingly, endogenous c-myb mRNA levels were maintained at quite high levels in c-fos-transfected clone 7 cells after Epo treatment ( Fig. 2A) , whereas Epo-induced differentiation normally leads to a rapid decline in c-myb transcripts (Fig.  lA) . This may be due to the inhibition of transcription shutoff (or the transcriptional activation) of the c-myb gene or, alternatively, may result from mRNA stabilization. Levels of c-myc mnRNA increased in c-fos-transfected clone 7 cells in response to Epo as they did in parental SKT6 cells (Figs. 1A  and 2A) , indicating that the regulation of this gene is not altered by exogenous c-fos expression.
In DMSO-treated c-fos-transfected clone 7 cells, the c-fos mRNA levels were not as high as those in Epo-treated cells. The endogenous c-myb mRNA was maintained at relatively high levels for 4 hr but thereafter decreased (Fig. 2B) . These findings suggest that the low levels of c-fos expression did affect the c-myb mRNA levels but not efficiently. The profile of c-myc mRNA levels was a biphasic decline (Fig. 2B) , which is similar to that of DMSO-induced parental cells (Fig.  1B) .
In c-myb-transfected clone 3 cells, extraordinarily high levels of c-myb mRNA were observed (Fig. 2 C and D) , since these cells contain endogenous and exogenous mRNAs that are not distinguishable by RNA blot analysis. These high levels were maintained upon Epo (Fig. 2C) or DMSO (Fig.  2D ) treatment, and no obvious effects of c-myb transfection on endogenous c-fos and c-myc gene expression were detected-i.e., the profiles of these mRNA levels in Epo-or DMSO-induced c-myb-transfected clone 3 cells (Fig. 2 C and  D) are very similar to those of SKT6 cells ( Fig. 1 A and B) .
Data obtained with c-fos-and c-myb-transfected cells (Table 1 and Fig. 2) , therefore, implicate down-regulation of c-myb (but not c-myc) as a prerequisite for Epo-induced erythroid differentiation.
Nuclear Run-On Transcription Assay of Epo-or DMSOInduced Cells. To investigate transcriptional control of endogenous c-myb and c-myc genes, run-on transcription assays were carried out by using nuclei from Epo (and DMSO)-induced SKT6 cells (Fig. 3A) . Fig. 3C shows the various mouse c-myb genomic (c, d, e, f, and i) and cDNA 0) fragments used as probes. The data show a decrease of c-myb transcription and an increase of c-myc transcription immediately following Epo induction of SKT6 cells (Fig. 3A) . Down-regulation of c-myb transcription is at the level of transcript initiation (see hybridization to fragments c, d, and e) as well as at the level of transcript elongation (fragments i andj) (Fig. 3A) . Initiation of the c-myb antisense transcript, which probably originates with the promoter region (fragment c) (33) , was found to coregulate with initiation of c-myb sense transcription in response to Epo (Fig. 3A) . The DMSO track indicates that down-regulation of c-myb expression is effected only at the level of a block to elongation (fragments i andj) (Fig. 3A) . These data are consistent with those ofRNA blot analysis ( Fig. 1 A and B) , except for the data of the 18-hr track. Reexpression of c-myb gene was observed in the 18-hr track, whereas RNA blot analysis showed a monotonic decrease of c-myb RNA after Epo treatment (Fig. 1A) . A rapid degradation mechanism for c-myb mRNA might exist in Epo-treated differentiating cells. Hybridization to mouse c-myc exon 1 (mycEl) and exon 2 (mycE2) shows an increase of exon 2 transcription, whereas transcription of exon 1 was not affected, indicating that increased expression of c-myc is effected at the level of a decrease in the block to elongation (Fig. 3A) .
Similarly, run-on assays of Epo-or DMSO-induced cfos-transfected clone 7 cells were performed (Fig. 3B) . The data show that there is little effect of Epo on c-myb transcription in c-fos-expressing SKT6 cells. Transcription initiation is not affected (fragments c, d, and e), nor is elongation (fragments i and j) (Fig. 3B) . However, DMSO still ablates c-myb elongation. Moreover, c-myc transcription still increases in response to Epo but not to DMSO. All ofthese data are consistent with those of RNA blot analyses (Fig. 2 A and  B) . The conclusion is that c-fos transfection blocks the down-regulation of endogenous c-myb expression upon Epo induction but has no effect on endogenous c-myc expression. The observed modulations in level of c-myb and c-myc mRNA upon Epo or DMSO induction disclosed by RNA blot analyses ( Figs. 1 and 2) were therefore found to be, at least in part, regulated at a transcriptional level. DISCUSSION Nuclear protooncogenes such as c-myb, c-fos, and c-myc are considered to play an important regulatory role in cell differentiation and proliferation (3) (4) (5) (6) . Therefore, it is critical to understand the molecular mechanism controlling the expression of these protooncogenes during cell differentiation.
We examined the changes of nuclear protooncogene expression during the early stage of Epo-and DMSO-induced erythroid differentiation when commitment for differentiation is determined. Although the natural differentiation factor and the chemical inducer lead to the same terminal erythroid cell differentiation, their effects upon expression patterns of nuclear oncogenes during early stage of differentiation appeared to be entirely different. This suggests that chemically induced differentiation bypasses the normal receptormediated signaling pathway-that is, although the effects of DMSO on nuclear protooncogene expression must be sufficient for differentiation, they may not truly reflect events that occur in response to Epo. Therefore, down-regulation of c-myc expression, which was demonstrated to be essential for chemically induced erythroid differentiation (16) (17) (18) (19) , appeared not to be required for Epo-induced differentiation, since, as shown in Figs. 1 and 3 , transcriptional activation of c-myc was observed in the Epo-induced differentiation process. We cannot exclude a requirement in Epo-induced differentiation for a late down-regulation of c-myc expression, as the levels of this transcript eventually decline at the late stage of terminal differentiation (Fig. 1) . It is likely, however, that the late down-regulation of c-myc expression is associated with cessation of cell proliferation, which is a necessary step for terminal differentiation. It has been shown that c-myc product promotes DNA replication and cell growth (34) . Aberrant expression of exogenous c-myc during the late stage of terminal differentiation process may thus lead to unlimited cell proliferation and consequently to inhibition of terminal cell differentiation. Rapid and transient c-fos expression observed in DMSO-induced cells (but not in Epo-induced cells) is similar to that observed in mitogen-or growth factor-stimulated cells (8, 9, 11, 13, (35) (36) (37) (38) , indicating that c-fos induction may not be related to the cell differentiation process. In monocyte-macrophage differentiation, it has been shown that c-fos induction is neither sufficient nor obligatory for differentiation (39, 40 (Fig. 3A) . On the contrary, DMSO-induced differentiation was not inhibited completely (Table 1 ). This may be because exogenous c-fos or c-myb expression in c-fos-or cmyb-transfected cells was neither high nor constant after DMSO induction (Fig. 2) and because c-myb expression was partially down-regulated in c-fos-transfected cells 10 hr after DMSO induction (Figs. 2 and 3) . Therefore, we decided not to draw any conclusions from the data of DMSO-induced differentiation.
Expression of the exogenous c-fos gene maintained high levels of c-myb mRNA even after Epo treatment ( Fig. 2A) , and this effect was found to be due to a block in downregulation of c-myb expression rather than to its mRNA stabilization (Figs. 3B and 4 ). Evidence obtained above that c-fos expression may influence c-myb transcription prompted us to examine the effect of the c-fos product on transcription from the c-myb promoter. A plasmid, pmybCAT, in which 1.7 kb of the mouse c-myb promoter region (41) was linked to chloramphenicol acetyltransferase (CAT) gene, was transfected into fibroblast L929 cells as well as into L929 cells expressing the exogenous c-fos gene using the DEAEdextran method (42) , and CAT assays were performed (43) . The result was that CAT activity in c-fos-transfected cells was slightly (two to five times) higher than that in untransfected cells (data not shown). Since the enhancement was not remarkably high, we cannot definitively conclude whether the c-fos product (or other nuclear proteins activated by c-fos) positively trans-activates the c-myb transcription or this effect resulted from inhibition of the Epo-induced downregulation of c-myb expression. There are 11 octanucleotide sequences similar to an AP-1 consensus sequence in mouse c-myb promoter region (between -250 and -1030), and, in fact, we detected several DNA binding proteins in this region by gel retardation assay (unpublished data). There is no evidence, however, that these AP-1-like sequences function as regulatory elements for c-myb gene expression. On the other hand, the c-fos product does not represent an obligate activation mechanism for c-myb gene expression, since SKT6 cells normally do not exhibit detectable levels of c-fos mRNA during Epo-induced differentiation, but they express rather high levels of c-myb mRNA (Fig. 1A) . Further analyses are necessary to clarify these phenomena.
It remains to be clarified how c-myb gene expression is regulated in hematopoietic cells. The nuclear extracts from SKT6 cells before and after Epo induction can be used to identify the positive and negative regulatory proteins for c-myb gene expression and the regulatory sequences in c-myb promoter. The identification of the signal that down-regulates c-myb expression may lead to the clarification of the molecular mechanism of Epo receptor-mediated erythroid differentiation.
